Psychometric properties of the SCOPA-AUT Brazilian Portuguese version

Movement Disorders

Volumn 25, Issue 2, 2010, Pages 205-212

  Carod Artal, Francisco Javier ^a   Ribeiro, Luciola Da Silveira ^a   Kummer, Wladimir ^a   Martinez Martin, Pablo ^b  

^a SARAH NETWORK OF REHABILITATION HOSPITALS   (Brazil)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Autonomic dysfunction; Parkinson's disease; SCOPA AUT questionnaire; Validity

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; BRAZIL; CARDIOVASCULAR SYSTEM; COLD; CONSTRUCT VALIDITY; CONTROLLED STUDY; CORRELATIONAL STUDY; CULTURAL FACTOR; DIAGNOSTIC ACCURACY; DISEASE DURATION; FECES INCONTINENCE; FEMALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ERROR; PARKINSON DISEASE; PORTUGAL; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; RELIABILITY; SALIVA; SCALE FOR OUTCOME IN PARKINSON DISEASE AUTONOMIC QUESTIONNAIRE; SYNCOPE; THERMOREGULATION;

AGED; BRAZIL; COGNITION; CROSS-CULTURAL COMPARISON; FEMALE; HUMANS; LANGUAGE; MALE; MIDDLE AGED; MOTOR SKILLS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 77649156829     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22882     Document Type: Article

References (29)

1. Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the non motor symptoms of Parkinson's disease. Mov Disord 2001;16:507-510.
2. Chaudhuri KR, Yates L, Martinez-Martin P. The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential. Curr Neurol Neurosci Rep 2005;5:275-283.
3. Jost WH. Autonomic dysfunction in Parkinson's disease. J Neurol 2003;250 (Suppl 1):I28-I30.
4. Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, van Hilten JJ. Patient-reported autonomic symptoms in Parkinson disease. Neurology 2007;69:333-341.
5. Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ. Assessment of autonomic dysfunction in Parkinson's disease: the SCOPAAUT. Mov Disord 2004;19:1306-1312.
6. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
7. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
8. Marinus J, Visser M, Stiggelbout AM, et al. A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA. J Neurol Neurosurg Psychiatry 2004;75:388-395.
9. Chaudhuri KR, Martinez-Martin P, Brown RG, et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord 2007;22:1901-1911.
10. Marinus J, Visser M, Verwey NA, et al. Assessment of cognition in Parkinson's disease. Neurology 2003;61:1222-1228.
11. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995;4:241-248.
12. Carod-Artal FJ, Martínez-Martin P, Kummer W, Ribeiro Lda S. Psychometric attributes of the SCOPA-COG Brazilian version. Mov Disord 2008;23:1-7.
13. Carod-Artal FJ, Martinez-Martin P, Vargas AP. Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version. Mov Disord 2007;2:91-98.
14. McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health surveys adequate? Qual Life Res 1995;4:293-307.
15. Ware JE, Gandek B. Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 1998;51:945-952.
16. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297-334.
17. Nunnally JC, Bernstein IH. Psychometric theory. New York: McGraw-Hill Inc; 1994.
18. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
19. Wyrwich KW, Nienaber MA, Tierney WM, Wolinsky FD. Linking clinical relevance and statistical significance in evaluating intraindividual changes in health-related quality of life. Med Care 1999;37:469-478.
20. Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: Attributes and review criteria. Qual Life Res 2002;11:193-205.
21. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987;42:773-778.
22. Juniper EF, Guyatt GH, Jaeschke R. How to develop and validate a new health-related quality of life instrument. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials, Second ed. Philadelphia: Lippincott-Raven Publishers; 1996. p 49-56.
23. Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29). A new patient-based outcome measure. Brain 2001;124:962-973.
24. Siddiqui MF, Rast S, Lynn MJ, Auchus AP, Pfeiffer RF. Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey. Parkinsonism Relat Disord 2002;8:277-284.
25. Magerkurth C, Schnitzer R, Braune S. Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life. Clin Auton Res 2005;15:76-82.
26. Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006;21:916-923.
27. ELEP Group. A longitudinal study of patients with Parkinson's disease (ELEP): aims and methodology. Rev Neurol 2006;42:360-365.
28. Idiaquez J, Benarroch EE, Rosales H, Milla P, Ríos L. Autonomic and cognitive dysfunction in Parkinson's disease. Clin Auton Res 2007;17:93-98.
29. Korchounov A, Kessler KR, Yakhno NN, Damulin IV, Schipper HI. Determinants of autonomic dysfunction in idiopathic Parkinson's disease. J Neurol 2005;252:1530-1536.